Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy
1 other identifier
interventional
150
1 country
1
Brief Summary
Hypothesis: Ventilator associated pneumonia (VAP) in critically ill patients may be prevented by continuous lateral rotation therapy (CLRT) using specially designed, motor driven beds. Patients are randomized to CLRT or supine position if mechanically ventilated and not suffering from pneumonia or ARDS within 48 hours after intubation. Prophylaxis of VAP is standardized in both groups. Primary endpoint is incidence of VAP, secondary endpoints are length of ventilation, length of stay and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2005
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 12, 2007
CompletedFirst Posted
Study publicly available on registry
September 14, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedJune 11, 2008
June 1, 2008
September 12, 2007
June 10, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventilator associated pneumonia
Secondary Outcomes (3)
Length of hospital stay
Length of mechanical ventilation
ICU and hospital Mortality
Study Arms (2)
1
ACTIVE COMPARATORContinuous lateral rotation therapy
2
NO INTERVENTIONStandard manual positioning (Supine position)
Interventions
Eligibility Criteria
You may qualify if:
- Mechanically ventilated
- Intubated not longer than 48 h
- Medical cause for ICU admission
- Expected to be ventilated for \> 48 hours
You may not qualify if:
- Pneumonia or ARDS present
- Postoperative patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vienna General Hospital, Medical University of Vienna
Vienna, 1090, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Staudinger, MD
Department of Internal Medicine I, Medical University of Vienna, Austria
- PRINCIPAL INVESTIGATOR
Thomas Staudinger, MD
Dept. of Internal Medicine I, Medical University of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2007
First Posted
September 14, 2007
Study Start
September 1, 2005
Study Completion
May 1, 2008
Last Updated
June 11, 2008
Record last verified: 2008-06